Back to User profile » Dr Mark A Giembycz

Paper published by Dr Mark A Giembycz:


Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

Mark A Giembycz, Stephen K Field

Drug Design, Development and Therapy 2010, 4:147-158

Published Date: 14 July 2010